[{"address1": "Schimmelt 2", "city": "Eindhoven", "zip": "NL-5656", "country": "Netherlands", "website": "https://www.onwd.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.", "fullTimeEmployees": 99, "companyOfficers": [{"maxAge": 1, "name": "Mr. David L. Marver", "age": 55, "title": "CEO & Executive Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 857284, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gregoire  Courtine Ph.D.", "age": 48, "title": "Chief Scientific Officer & Director", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Khaled  Bahi", "age": 57, "title": "Interim Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert W. Odell", "age": 63, "title": "Vice President of Operations", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lorenzo  Fanti", "title": "Vice President of Legal", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Moore", "title": "Vice President of Global Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Julie  Crom", "title": "Director of People & Culture", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "open": 5.99, "dayLow": 5.99, "dayHigh": 5.99, "regularMarketOpen": 5.99, "regularMarketDayLow": 5.99, "regularMarketDayHigh": 5.99, "beta": 0.836, "volume": 100, "regularMarketVolume": 100, "averageVolume": 372, "averageVolume10days": 25, "averageDailyVolume10Day": 25, "marketCap": 192680400, "fiftyTwoWeekLow": 3.77, "fiftyTwoWeekHigh": 7.13, "priceToSalesTrailing12Months": 362.1812, "fiftyDayAverage": 5.6156, "twoHundredDayAverage": 5.127525, "trailingAnnualDividendYield": "NaN", "currency": "USD", "enterpriseValue": 145272192, "floatShares": 15840767, "sharesOutstanding": 34628800, "heldPercentInsiders": 0.18937, "heldPercentInstitutions": 0.35127997, "bookValue": 0.594, "priceToBook": 9.259259, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -36181000, "trailingEps": -1.33, "enterpriseToRevenue": 273.068, "enterpriseToEbitda": -4.123, "exchange": "OEM", "quoteType": "EQUITY", "symbol": "ONWRF", "underlyingSymbol": "ONWRF", "shortName": "ONWARD MEDICAL NV", "longName": "Onward Medical N.V.", "firstTradeDateEpochUtc": 1685626200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "77b87ecd-bc39-3c9e-bce0-ce255bb609b2", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.5, "recommendationKey": "none", "totalCash": 29768000, "totalCashPerShare": 0.986, "ebitda": -35234000, "totalDebt": 16874000, "quickRatio": 4.518, "currentRatio": 4.704, "totalRevenue": 532000, "debtToEquity": 94.105, "revenuePerShare": 0.018, "returnOnAssets": -0.36872002, "returnOnEquity": -1.0255101, "freeCashflow": -21077376, "operatingCashflow": -32270000, "operatingMargins": 42.128788, "financialCurrency": "EUR", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]